In view of World Cancer Day, the European Patent Office (EPO) has published its second study on oncology technologies, p...
SOPHiA GENETICS empowers hematologic cancer research at Centre Hospitalier De Bastia with Ai-Driven Platform
On July 2023, SOPHiA GENETICS, a leading data-driven medicine company, has announced that the Centre Hospitalier de Bast...
Genenta Science: Temferon™ for the treatment of glioblastoma
Genenta Science, a clinical-stage immuno-oncology company, has received Orphan Drug Designation (ODD) from the European ...